| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.42 | 1e-08 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.41 | 2e-08 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.36 | 1e-06 |